Kainate agonist; excitant and neurotoxin
Kainic acid, also known as kainate, is a selective agonist of kainate ionotropic glutamate receptors (EC50 = 0.6 μM - 7.4 μM) and a partial agonist at AMPA receptors (EC50 = 31 μM - 170 μM). Kainic acid is used to model epilepsy
in vivo
and to study the mechanisms of neurodegeneration and neurocytosis induced by excess stimulation by kainic acid. Kainate is shown to be involved in amyloidogenic processing of amyloid precursor protein and Aβ peptides in Alzheimer's. Synthetic version of Kainic acid (Cat. No. 0222)
Related compounds include the kainate receptor agonist Domoic acid (Cat. No. 0269) and the antagonist NBQX (Cat. No. 0373).
| Marque | Tocris Bioscience |
|---|---|
| Réf. B-LABO | BL-RE-160828 |
| Réf. fabricant | 18717446 |
| Nom chimique ou matériau | (2S,3S,4S)-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid |
| CAS | 487-79-6 |
| Quantité | 50 mg |
| Formule moléculaire | C<sub>10</sub>H<sub>15</sub>NO<sub>4</sub> |
| Pureté | 98% |
